Status: current, Defined. Date: 30-Jun 2015. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3031801000168112 | B-Dose Forte (Biological Therapies) (cyanocobalamin 1 mg / 2.5 mL + dexpanthenol 50 mg / 2.5 mL + nicotinamide 50 mg / 2.5 mL + pyridoxine hydrochloride 100 mg / 2.5 mL + riboflavin sodium phosphate 5 mg / 2.5 mL + thiamine hydrochloride 250 mg / 2.5 mL) injection, 6 x 2.5 mL vials (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3031811000168110 | B-Dose Forte (Biological Therapies) injection, 6 x 2.5 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
B-Dose Forte (Biological Therapies) injection, 6 x 2.5 mL vials | Is a | containered trade product pack | true | Inferred relationship | Some | ||
B-Dose Forte (Biological Therapies) injection, 6 x 2.5 mL vials | Is a | B-Dose Forte (Biological Therapies) injection, 6 x 2.5 mL vials | true | Inferred relationship | Some | ||
B-Dose Forte (Biological Therapies) injection, 6 x 2.5 mL vials | has container type | vial | true | Inferred relationship | Some | ||
B-Dose Forte (Biological Therapies) injection, 6 x 2.5 mL vials | has TPUU | B-Dose Forte (Biological Therapies) injection, 2.5 mL vial | true | Inferred relationship | Some | 1 | |
B-Dose Forte (Biological Therapies) injection, 6 x 2.5 mL vials | has TP | B-Dose Forte (Biological Therapies) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set